Protein Engineering Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ZYME | C | Zymeworks Inc. | 4.46 | |
MURA | D | Mural Oncology plc | -0.59 | |
IGMS | F | IGM Biosciences, Inc. | 0.00 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | F | Virtus LifeSci Biotech Clinical Trials ETF | 1.03 | |
CNCR | F | Loncar Cancer Immunotherapy ETF | 0.88 | |
QQQS | B | Invesco NASDAQ Future Gen 200 ETF | 0.47 | |
WCEO | B | Hypatia Women CEO ETF | 0.29 | |
IWC | B | iShares Microcap ETF | 0.26 |
Compare ETFs
- Protein Engineering
Protein engineering is the process of developing useful or valuable proteins. It is a young discipline, with much research taking place into the understanding of protein folding and recognition for protein design principles. It is also a product and services market, with an estimated value of $168 billion by 2017.There are two general strategies for protein engineering: rational protein design and directed evolution. These methods are not mutually exclusive; researchers will often apply both. In the future, more detailed knowledge of protein structure and function, and advances in high-throughput screening, may greatly expand the abilities of protein engineering. Eventually, even unnatural amino acids may be included, via newer methods, such as expanded genetic code, that allow encoding novel amino acids in genetic code.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles